(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025 financial results on Wednesday, January 28, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast […]
(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q4 2025 Aide Memoire is available on the “Investors” page on its website. Q4 2025 Aide Memoire Teva has compiled this document with public information that was previously provided by Teva in order
A first of its kind randomized trial showed higher survival rates and significantly fewer side effects for patients receiving proton therapy for certain head and neck cancers The study, published today inThe Lancet,showed results from the largest of its kind Phase III trial. Led by researchers at the University of Texas MD Anderson Cancer Center,
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 12, 2025 CELEBRATION, Fla., Dec. 12, 2025 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that the Company has granted options to purchase an
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 GlobeNewswire December 12, 2025 TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025
Teva Releases Q4 2025 Aide Memoire GlobeNewswire December 12, 2025 TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q4 2025 Aide Memoire is available on the “Investors” page on its website. Q4 2025 Aide Memoire Teva has compiled this document with public
Grande Group Limited Announces Financial Results for the First Half of Fiscal Year 2026 GlobeNewswire December 12, 2025 Hong Kong, Dec. 12, 2025 (GLOBE NEWSWIRE) — GRANDE GROUP LIMITED (“GRAN” or the “Company”) (Nasdaq: GRAN), a Hong Kong-based financial services provider which principally engages in the provision of corporate finance advisory services and IPO sponsor
Levi & Korsinsky Notifies Firefly Aerospace Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – FLY GlobeNewswire December 12, 2025 NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Firefly Aerospace Inc. (“Firefly Aerospace Inc.” or the “Company”) (NASDAQ: FLY) of a class action securities lawsuit. CLASS
(NASDAQ:SNPS), NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Synopsys, Inc. (“Synopsys, Inc.” or the “Company”) (NASDAQ: SNPS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Synopsys, Inc. investors who were adversely affected by alleged securities fraud between December
(NYSE:FCX), NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Freeport-McMoRan Inc. (“Freeport-McMoRan Inc.” or the “Company”) (NYSE: FCX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Freeport-McMoRan Inc. investors who were adversely affected by alleged securities fraud between February